In a new preclinical study, scientists present a molecular engineering approach to modify and repurpose a cytokine named ...
CANTANHEDE, Portugal, Nov. 5, 2026 /PRNewswire/ -- Mondego Bio today announced the initiation of a first-in-human Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results